Meanwhile, Bengaluru-based brokerage firm Zerodha ranked fourth with a Rs 87,750 crore valuation, marking a 50 percent rise ...

Rocket Doctor's virtual care model reduces unnecessary emergency department (ED) visits, reduces wait times, and ensures timely specialist referrals. With services now live, eligible plan members can ...

Upstart Holdings reported a surprising Q4 EPS of $0.04, beating expectations. Find out why I rate UPST stock as a strong buy.

Great Learning saw a year of turnaround and profitability, taking back control from BYJU'S amidst its AI makeover ...

Coding platform Replit is using generative AI to empower anyone to write software and create apps. Here's how.

The company's total leverage manageable. As of December 2024, Stifel had a 11.4% Tier 1 leverage ratio compared with management's previously stated target of 10%, implying that the firm is carrying ...

I think we have a team, like you saw last year, that’s capable of going down and accomplishing our goal,” Greupner said.

Value stocks have had a difficult time over the last decade, but things could be looking up, especially for investors who ...

A handful of high-flying technology stocks led the stock market to new all-time highs in 2024, and the Technology Select ...

We assign a Medium Morningstar Uncertainty Rating to Moody’s.

JPMorgan Asset Management’s Kerry Craig said in a latest program on CNBC that investors are looking beyond the top AI ...

Axsome Therapeutics demonstrated robust revenue growth in Q4 2024, outpacing expectations despite higher-than-anticipated ...